ACI Archean Chemical Industries Q2 FY26 results (Jul–Sep 2025) and concall
Archean Chemical reported a mixed Q2 FY26, with standalone revenue declining 8% YoY to INR 2,317.8 million, while H1 FY26 revenue grew 10% to INR 5,232.3 million. Key highlights include the India semiconductor mission approval for its SiCSem project and successful SOP pilot trials. However, the company faced challenges with elemental bromine production efficiencies, industrial salt volumes impacted by monsoon, and delays in the revival of Oren Hydrocarbon operations. An income tax search and seizure operation also occurred during the quarter.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue down 7.1%, net profit up 72.7% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 238 | 243 | 322 | 279 | 221 −7% |
| EBITDA | 76 | 84 | 90 | 83 | 65 −14% |
| Net profit | 22 | 56 | 58 | 52 | 38 +73% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
